Trial Profile
Randomized study of two doses of oral valacyclovir in immunocompromised patients with uncomplicated herpes zoster
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Herpes zoster
- Focus Therapeutic Use
- 03 Oct 2005 New trial record.